CDKN2A and cancer: These data indicate that as a single variant, ATM Ser49Cys is benign, in agreement with its classification in ClinVar, but the early onset of cancers in probands carrying the ATM Ser49Cys and CDKN2A p14ARF variants suggest that the ATM variant may act as a modifier of risk via impaired senescence.